MEDICAL DEVICE PROFILE
TruSight Oncology Comprehensive
Explore the manufacturer, product identifiers and associated FDA decisions for this device.
- Manufacturer / applicant
- Illumina, Inc.
- Product code
- PQP
- Unique device identifier
- Not reported
- Indications for use
- Not reported
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
TruSight Oncology ComprehensiveP230011/S008 | Illumina, Inc. | PMA supplement | Sep 4, 2026 | FDA |
TruSight Oncology ComprehensiveP230011/S006 | Illumina, Inc. | PMA supplement | Aug 14, 2026 | FDA |
TruSight Oncology ComprehensiveP230011/S002 | Illumina, Inc. | PMA supplement | Jun 26, 2026 | FDA |
TruSight Oncology ComprehensiveP230011/S007 | Illumina, Inc. | PMA supplement | Apr 23, 2026 | FDA |
TruSight Oncology ComprehensiveP230011/S005 | Illumina, Inc. | PMA supplement | Sep 19, 2025 | FDA |
TruSight Oncology ComprehensiveP230011/S004 | Illumina, Inc. | PMA supplement | Sep 5, 2025 | FDA |
| Illumina, Inc. | PMA approval | Aug 21, 2024 | FDA |
Source information
Retrieved Nov 20, 2026.





